Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Infant deaths during a trial of a medicine that protects against respiratory syncytial virus were caused by unrelated factors ...

The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Infants will be able to receive a free immunisation to protect them against serious illness from respiratory syncytial virus (RSV), under a new $16.6 million NSW Government RSV prevention program to ...

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

A WHO official this week said repatriation is one of multiple factors fueling rises in Pakistan and Afghanistan.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

MemorialCare Miller Children's & Women's Hospital Long Beach has been recognized by the California Department of Public ...

The good news: In October, a new preventive medicine, the monoclonal antibody Nirsevimab, became available to babies and at-risk toddlers to help protect them from RSV (Respiratory Syncytial Virus).